6533b7d3fe1ef96bd126088d
RESEARCH PRODUCT
455P Concordance of baseline RAS mutational status (ms) between tissue and cell-free DNA (cfDNA) and association with overall response rate (ORR) in first-line (1L) metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study (cohort 2) (NCT02792478)
P. García-alfonsoL. Cirera NoguerasA.m. López MuñozManuel Valladares-ayerbesE. González-floresM. Salgado FernándezRocio Garcia-carboneroJuan J. Cruz-hernándezJorge AparicioE. Aranda AguilarA. Salud SalviaO.a. Castillo TrujilloE. Falco FerrerA. Lloansi VilaP. Pimentel CáceresM.a. Vicente ConesaN Rodríguez SalasMarta LlanosB. Massuti SuredaMaria Jose Safontsubject
Oncologymedicine.medical_specialtyColorectal cancerbusiness.industryConcordanceFirst lineHematologymedicine.diseaseOverall response rateOncologyCell-free fetal DNAInternal medicineCohortmedicineMutational statusbusinessyear | journal | country | edition | language |
---|---|---|---|---|
2021-09-01 | Annals of Oncology |